Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)

CompletedOBSERVATIONAL
Enrollment

1,384

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

November 22, 2020

Study Completion Date

November 22, 2020

Conditions
Acute Infection
Interventions
DIAGNOSTIC_TEST

MeMed BV

The MeMed BV™ Test is an immunoassay that measures three non-microbial (host) proteins (TRAIL, IP-10, and CRP) in adult and pediatric serum samples. The test is intended for use in conjunction with clinical assessments and other laboratory findings as an aid to differentiate bacterial from viral infection. The test is indicated for use in patients presenting to the ED, urgent care center and inpatients with suspected acute bacterial or viral infection. The MeMed BV™ Test generates a numeric score that falls within discrete interpretation bins based on the increasing likelihood of bacterial infection. The MeMed BV™ test is intended for in vitro diagnostic use only.

Trial Locations (11)

11219

Maimonides Medical Center, New York

15260

University of Pittsburgh Medical Center, Pittsburgh

21218

Johns Hopkins, Baltimore

29611

American Family Care Urgent Care, Powdersville

29640

American Family Care Urgent Care, Easley

37421

American Family Care Urgent Care, Chattanooga

38100

Hillel Yaffe Medical Center, Hadera

77030

Texas Children's Hospital, Houston

University of Texas Health Science Center, Houston

3436212

Carmel Medical Center, Haifa

02115

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
lead

MeMed Diagnostics Ltd.

INDUSTRY

NCT04690569 - Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY) | Biotech Hunter | Biotech Hunter